Comparison of Motor Relearning and Neurodevelopmental Therapy in Stroke Patients
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 15, 2022
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
Stroke is one of the leading causes of death and the commonest cause of long-term disability in adults. In Pakistan it is also prevalent with prevalence of 1.24%, having common risk factor hypertension, diabetes, dyslipidemia and smoking. The focus of stroke rehabilitation is largely on the recovery of impaired movements and functions as it often leads to balance impairment and impaired postural control and mobility. The diagnosis and management of acute ischemic stroke are limited by the lack of rapid diagnostic assays for use in an emergency setting. Computed tomography (CT) scanning is u...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both male and female, with age between 45-70 years
- • First-time unilateral stroke confirmed by magnetic resonance imaging or computed axial tomography scan.
- • Clinically stable with fully oriented and conscious.
- • Subacute stroke patients.
- • Patients having lower limb dysfunction.
- • Patients with Mini Mental State Examination MMSE score ≥ 24
- Exclusion Criteria:
- • Recurrent stroke.
- • Foot drop
- • Cardiac disease that limit function by exertional dyspnea, angina or severe fatigue.
- • Any visual and hearing problem
- • Subarachnoid or extradural hemorrhage, progressive hydrocephalus, previous history of brain injury
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Binash Afzal, PHD*
Principal Investigator
Riphah international university lahore campus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials